Spunweb Nonwoven IPO

Incorporated in 2015, Spunweb Nonwoven Limited is a manufacturer and supplier of non-woven fabrics, primarily used for applications like doormats, bags, carpets, and tarpaulins. They are recognized for their quality control system, which includes testing, inspection, and analysis to ensure high-quality products. The company manufactures nonwoven fabric, laminated, and UV-treated nonwoven fabric. The company operates state-of-the-art testing facilities, which include Universal Tensile Testing and Rewet Properties Testing. The company exports its products to North America, Europe, and the Middle East. More than two-thirds of its revenue is generated from the demand for fabric in the hygiene sector, while the remaining portion is derived from applications in the medical, packaging, agriculture, and construction industries. The company's clients include RGI Meditech Private Limited, Millenium Babycares Limited, Sekhani Industries Private Limited, Myra Hygiene Products Private Limited, Rotech Healthcare Private Limited, Poligof Micro Hygiene (India) Private Limited, Salus Products Private Limited, Kwalitex Healthcare Private Limited, JDS Nonwoven, Vyom Nonwoven, among others. The company has exported its products to countries such as the United States of America, United Arab Emirates, Italy, Egypt, Saudi Arabia, Sri Lanka, Nepal, Kenya and Nigeria. The company has a manufacturing facility situated in Rajkot, Gujarat. Product Portfolio: Hydrophobic Fabric, Hydrophilic Fabric and UV-Treated Fabric. As of May 31, 2025, the company had 199 employees. Competitive Strength: One of the largest manufacturers of spunbond nonwoven fabrics in India Tailored spunbond nonwoven fabric manufacturing for industry specific needs. A long-standing association with different consumers in diverse industries and geographies. Advanced spunbond technology along with cleanroom technology for the manufacturing process. Experienced Promoters supported by a strong management and execution team.

The Company Spunweb Nonwoven IPO proposes to utilise the Net Proceeds from the Issue towards the following objects: S.No. Objects of the Issue Expected Amount (in Million) 1 Funding the working capital requirements of the company 290 2 Investment in the wholly owned subsidiary, SIPL, for funding its working capital requirements 100 3 Repayment, in full or in part, of certain borrowings availed by the company 80 4 General Coporate Purposes

All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application. No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever Please read all Tearms and conditions , and agree to use the App